European Union: Difference between revisions
Tag: Reverted |
|||
| Line 16: | Line 16: | ||
=== [[hasDatabase:: Database: EUROCARE (European Union-wide Resources) | Database: EUROCARE]] === | === [[hasDatabase:: Database: EUROCARE (European Union-wide Resources) | Database: EUROCARE]] === | ||
{{forresearchers}} | |||
Go back to [[European Union]] page | |||
'''Primary purpose:''' To monitor cancer survival, measure cancer prevalence, and study patterns of care for cancer patients across Europe. [https://www.iss.it/en/eurocare-il-progetto Click here to learn more.] | |||
'''Sponsor, manager or home institution:''' [[dataOwner::the Istituto Nazionale dei Tumori (INT Milan)]] and the [[dataOwner::Istituto Superiore di Sanità (Rome)]]. Patient-level data is owned by each individual cancer registry. [https://eu5results.iss.it/docs/Documentation_on_data_and_%20methods.pdf Click here to learn more]. | |||
'''Type of information:''' Cancer Site, Population, Age Class, ICSS - International Cancer Survival Standards, Time from Diagnosis, Sex, and Output Indicators including: Alive at Start, Observed Survival, Cumulative (OSC), Relative Survival, Cumulative (RSC), Relative SE's, Cumulative (RSEC), Dead, Expected Survival, Interval (ESI), Observed SE's, Interval (OSEI), RSC: Lower bound (95% CI), Lost to Follow Up, Expected Survival, Cumulative (ESC), Observed SE's, Cumulative (OSEC), RSC: Upper bound (95% CI), Observed Survival, Interval (OSI), Relative Survival, Interval (RSI), Relative SE's, Interval (RSEI). | |||
'''Source of Information:''' 99 cancer registries from 29 countries participating in the study provided their patient-level data as of the 5th Edition of EUROCARE. [https://eu5results.iss.it/docs/Documentation_on_data_and_%20methods.pdf Click here to learn more]. | |||
'''Data level:''' [[dataLevel::national level]]. | |||
'''Number of Records:''' [[numberRecords::9,000,000]]. [https://eu5results.iss.it/docs/Documentation_on_data_and_%20methods.pdf Click here to learn more]. | |||
'''Date range:''' [[dataStart::2000]] to [[dataEnd::2007]]. | |||
'''Cancer Areas of Interest:''' [[hasCancerType::C00-C97: All cancer types]]. | |||
'''Data access:''' [[dataAvailability::publicly available]]. [https://eu5results.iss.it/forms/SA0007.aspx Click here to access]. Databases from previous editions of the EUROCARE study are also available. [https://www.iss.it/en/eurocare-database Click here to learn more]. | |||
'''Contact information:''' [https://www.iss.it/en/eurocare-chi-siamo Click here to learn more.] | |||
=== [[hasDatabase::Database:_NordScreen_(European_Union_-_wide_Resources)|Database: NordScreen]] === | === [[hasDatabase::Database:_NordScreen_(European_Union_-_wide_Resources)|Database: NordScreen]] === | ||
Revision as of 14:08, 29 April 2024
Go back to Cancer Centers list.
Administrative or Claims Data
Database: European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
Registries
Compilation: Eurostat
Database: OECD Health Statistics
Compilation: WHO Health Data
Database: European Cancer Information System (ECIS)
Database: EUROCARE
Go back to European Union page
Primary purpose: To monitor cancer survival, measure cancer prevalence, and study patterns of care for cancer patients across Europe. Click here to learn more.
Sponsor, manager or home institution: the Istituto Nazionale dei Tumori (INT Milan) and the Istituto Superiore di Sanità (Rome). Patient-level data is owned by each individual cancer registry. Click here to learn more.
Type of information: Cancer Site, Population, Age Class, ICSS - International Cancer Survival Standards, Time from Diagnosis, Sex, and Output Indicators including: Alive at Start, Observed Survival, Cumulative (OSC), Relative Survival, Cumulative (RSC), Relative SE's, Cumulative (RSEC), Dead, Expected Survival, Interval (ESI), Observed SE's, Interval (OSEI), RSC: Lower bound (95% CI), Lost to Follow Up, Expected Survival, Cumulative (ESC), Observed SE's, Cumulative (OSEC), RSC: Upper bound (95% CI), Observed Survival, Interval (OSI), Relative Survival, Interval (RSI), Relative SE's, Interval (RSEI).
Source of Information: 99 cancer registries from 29 countries participating in the study provided their patient-level data as of the 5th Edition of EUROCARE. Click here to learn more.
Data level: national level.
Number of Records: 9,000,000. Click here to learn more.
Date range: 2000 to 2007.
Cancer Areas of Interest: C00-C97: All cancer types.
Data access: publicly available. Click here to access. Databases from previous editions of the EUROCARE study are also available. Click here to learn more.
Contact information: Click here to learn more.
